Measles-containing-vaccine first-dose (MCV1) immunization coverage in Republic of Korea
Republic of Korea: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 97.0% in 2025. ▬ Flat
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Republic of Korea, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine first-dose (mcv1) immunization coverage in Republic of Korea is 97.0%, measured in 2025.
Compared with earlier readings it is down 1.0% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Republic of Korea peaked at 99.0% in 2004 and was at its lowest, 92.0%, in 2007.
Republic of Korea ranks 33rd of 194 countries on this measure, in the top quarter.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Republic of Korea, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 95.0% | — |
| 2001 | 96.0% | +1.1% |
| 2002 | 97.0% | +1.0% |
| 2003 | 96.0% | -1.0% |
| 2004 | 99.0% | +3.1% |
| 2005 | 99.0% | +0.0% |
| 2006 | 99.0% | +0.0% |
| 2007 | 92.0% | -7.1% |
| 2008 | 92.0% | +0.0% |
| 2009 | 93.0% | +1.1% |
| 2010 | 98.0% | +5.4% |
| 2011 | 99.0% | +1.0% |
| 2012 | 99.0% | +0.0% |
| 2013 | 99.0% | +0.0% |
| 2014 | 99.0% | +0.0% |
| 2015 | 98.0% | -1.0% |
| 2016 | 98.0% | +0.0% |
| 2017 | 97.0% | -1.0% |
| 2018 | 98.0% | +1.0% |
| 2019 | 98.0% | +0.0% |
| 2020 | 98.0% | +0.0% |
| 2021 | 98.0% | +0.0% |
| 2022 | 97.0% | -1.0% |
| 2023 | 97.0% | +0.0% |
| 2024 | 97.0% | +0.0% |
| 2025 | 97.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 95.8% | 92.0% | 99.0% | 10 |
| 2010s | 98.3% | 97.0% | 99.0% | 10 |
| 2020s | 97.3% | 97.0% | 98.0% | 6 |
Countries ranked near Republic of Korea
More health data for Republic of Korea
- Un projection of annual infant deaths, annual growth rate -1.43 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1935 % change on previous year (2090)
- Heat deaths vs projected death rates 2,072 (2090)
- Un projection of annual infant deaths 69 (2100)
- Population ages 0-14, total, annual growth rate -3.57 % change on previous year (2025)
- Population ages 0-14, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, total, per capita 0.102 units per person (2025)
- Population ages 15-64, female, annual growth rate -1.16 % change on previous year (2025)
- Population ages 15-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, female, per capita 0.3376 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Republic of Korea?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Republic of Korea was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Republic of Korea?
- The highest recorded value was 99.0% in 2004.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Republic of Korea?
- The lowest recorded value was 92.0% in 2007.
- How does Republic of Korea rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Republic of Korea ranks 33rd out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Republic of Korea?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is flat.
- Where does this Republic of Korea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).